Market Strategy Using Patent Data Analysis

Mark D. Bauer

Online Services

Derwent North America

Discussion Topics

• Introduction

• Strategy

• Questions

• Drilling Techniques

• Assumptions

• Conclusions

• Unique resource

• Geography

• Chronology

• The Marketplace

• The Sharp Advantage

• Commercial Databases

• Case study

Introduction

Unique Resource

• Hard Data

• Technology & Market Profile

• Prosecution and Maintenance– $250,000 = 1 patent

Strategy

• Portfolio Management

• Licensing Technology

• Patent Value vs. Investment

• Corporate Goals

Questions

• Where are the Competitors?– Priority Country

• Where is the Market?– Publication Country

• Who are the New players?– Patentee Codes

• Do Industry Icons Develop the New Technology?– Patent Classification

Drilling Techniques

PFIZ - Patentee CodeDerwent Codes for

CNS and Tranquilizers

450 hits

SSRI,Serotonin & Inhibit?

& Pfizer16 hits

Drilling Techniques

KeywordsCompany

NamesDates

ClassificationsCodesIndexing

SSRI,Serotonin& PFIZ

& CODES38 hits

ModifiedKeywordsCompany

NamesDatesCodes

Drilling Techniques

• Pharmaceuticals in 2000

– US 13070– EPO equiv. 922– WO equiv. 9074

Assumptions

• Data must be viewed as subject to various factors– Full Text– Backfile– Subject Coverage– Country Coverage– Quality

Assumptions

• Patent Issuing Authority– Australian PCT Pubs– Japanese Kokai– Germany & Spain EP pubs– National Phase PCT

• Prosecution Strategy– minimize exposure– maximize exposure

0

20

40

60

80

100

120

140

160

Number of Inventions

1980 1981 1982 1983 1984 1986 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001Basic Publication Year

IBM patents filed as PCT

IBM Patents filed as PCT - Comparison of PCTs vs Total

0

500

1000

1500

2000

2500

3000

3500

4000

1980 1981 1982 1983 1984 1986 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001

Basic Publication Year

PCT

Total

SSRI Patent Activity by Priority Year

0

20

40

60

80

100

120

140

160

1957

1961

1963

1965

1967

1969

1971

1974

1976

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

Priority Year

Nu

mb

er

of

Inv

en

tio

ns

0

20

40

60

80

100

120

140

160

Number of Inventions

1957

1961

1963

1965

1967

1969

1971

1974

1976

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

Priority Year

SSRI Granted vs Total of Applications

Granted Patents Total of All Applications

SSRI Patent Activity by Priority Country

0

50

100

150

200

250

300

350

400

450

500

US

GB JP FR

DE

CH

EP

DK IT

WO ES

SE

AU ZA IN SU

BR

CA

HU

BE

CN IE NL

HR

AR

CS

KR

MX

NO PH

RO

TW YU

WIPO Country Codes

Nu

mb

er

of

Inv

en

tio

ns

1957

1961

1963

1965

1967

1969

1971

1974

1976

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

AR

CS

NL

YU

DK

FR

0

10

20

30

40

50

60

70

80

90

Number of Inventions

Priority Year

WIPO Country Codes

SSRI Patent Activity - Priority Year/Country

1957

1961

1963

1965

1967

1969

1971

1974

1976

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

WO

IT

GB

0

10

20

30

40

50

60

70

80

90

SSRI in Major Countries

WO

DK

DE

EP

IT

SE

JP

FR

GB

US

1957

1961

1963

1965

1967

1969

1971

1974

1976

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

TW

BR

0

0.5

1

1.5

2

2.5

3

3.5

4

4.5

5

SSRI in Minor Countries

TW

YU

ZA

BR

ES

IN

1957

1961

1963

1965

1967

1969

1971

1974

1976

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

AR

CH

0

0.5

1

1.5

2

2.5

3

3.5

4

SSRI Minor Countries

AR

AU

BE

CA

CH

CN

CS

HR

Highly Cited Patents

TI New 1-(hetero)aryl-3-piperazino or tetra hydro pyridyl-1H-indole cpds. - are dopaminergic and 5-HT antagonists useful for treating psychoses.

DC B02

IN PERREGAARD, J K

PA (LUND) LUNDBECK H A/S; (LUND) LUNDBECK AS H

CYC 23

PI EP 200322 A 19861105 (198645)* EN 33p

PNC.GX 96 Citing Patents Count (by examiner)

Highly Cited Patents

TI Benzoic acid piperidyl ester(s) contg. alkylene bridges - in piperidyl ring are used as antipsychotics for treatment of cardiac-circulatory disorders.

DC B02 B03

IN ENGEL, G; HUEGI, B; RICHARDSON, B P; STADLER, P; DONATSCH, P; HUGI, B; STADLER, P A

PA (DONA-I) DONATSCH P; (SANO) SANDOZ AG; (SANO) SANDOZ PATENT GMBH; (NOVS) NOVARTIS AG; (SANO) SANDOZ LTD

CYC 21

PI DE 3322574 A 19831229 (198402)* 62p

PNC.GX 179 Citing Patents Count (by examiner)

Conclusions

• New Pieces for Puzzle

• Global View of Market

• Comprehensive Technology Review

Online Assistance

• 800 Derwent

• www.derwent.com

• custserv@derwent.co.uk

• Mark.Bauer@derwentus.com